A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia

Autor: Lancet, Jeffrey E., Baer, Maria R., Duran, George E., List, Alan F., Fielding, Robert, Marcelletti, John F., Multani, Pratik S., Sikic, Branimir I.
Zdroj: In Leukemia Research 2009 33(8):1055-1061
Databáze: ScienceDirect